IPO Date: Dec 8 to Dec 10 2025
Listing Date: Dec 15 2025
C – Mondeal Business Park Near Gurudwara, S. G. Highway Thaltej
Ahmedabad
Gujarat
380059
079 4023 3000
complianceofficer@coronaremedies.com
www.coronaremedies.com
Bigshare Services Pvt Ltd
CORONA Remedies has informed the Board of Directors, at its meeting held on Friday, July 31, 2026 had considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated) for the first quarter and three months ended on June 30, 2026. Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it has enclosed the newspaper advertisement of the Unaudited Financial Results, published today in Financial Express (English and Gujarati). The extract of aforesaid newspaper publication is also being made available on the website of the Company at www.coronaremedies.com.
The above information is a part of company’s filings submitted to BSE.
Union Minister Piyush Goyal has said that the commerce ministry is working with state governments to organise a series of free trade agreement (FTA) outreach initiatives across the country, to help every state unlock its unique export potential, ensure greater utilisation of these FTAs and give fresh momentum to India's export growth.
The minister said the multiple FTAs concluded in recent years have opened up immense opportunities for India’s exporters. He said ‘the government's focus is on ensuring these benefits reach our farmers, workers, women, youth, MSMEs and small businesses, enabling them to take more 'Made in India' products to global markets.’
In the last five years, India has implemented free trade agreements with the UAE, Mauritius, Australia, Oman, EFTA bloc, the UK and New Zealand.
According to the data released by the NSE, the Foreign Institutional Investors (FIIs) were net sellers of Rs 8902.64 crore in index futures and options segments, as per Wednesday’s data, October 21, 2026.
FIIs were net buyers of index futures to the tune of Rs 255.90 crore and net sellers of index options worth Rs 9158.54 crore. In the stock segment, FIIs were net buyers of stock futures worth Rs 2548.66 crore and they bought stock options worth Rs 283.34 crore.
No Records Found
The issue size of CORONA Remedies Ltd. IPO is ₹460.85 - 485.53 crore.
The CORONA Remedies Ltd. IPO opens for subscription on 2025-12-08 and closes on 2025-12-10.
The price range of CORONA Remedies Ltd. IPO is ₹1,008.00 to ₹1,062.00.
The lot size of CORONA Remedies Ltd. IPO is 14 shares.
The registrar of CORONA Remedies Ltd. IPO is Bigshare Services Pvt Ltd .
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.